Aggrade is a UK company, holding IP rights for AGS technology, a dry, continuous process for the granulation of different sorts of API’s (Pharmaceutical raw materials). Drugs in granulate form are utilized for the manufacturing of tablets, capsules, and sachets.
In 2015 Medeor, together with other private investors and industry experts, acquired a significant minority stake in Aggrade.
Aggrade owns a pilot/industrial scale AGS plant which has been installed in Sabaudia (Center-South Italy), as part of Pharma DGTech (www.pharmadgtech.it) a Joint Venture with STB Valitech, an engineering company specialized in pharmaceutical plants.
The first industrial scale AGS plant, under Aggrade licensing, has been commissioned in Poland in 2020.